Companies: 10,795·Total market cap: $144.5T
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc.

HTSUFOTCHealthcare
$29.00
+$0.00(+0.00%)
Market Cap$2.0B
P/E Ratio
52W High$32.3
52W Low$28.94
Overview

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · HTSUF · as of Jun 8, 2026

Key Statistics

EPS (TTM)$269.53htsuf eps ttm · htsuf earnings per shareEarnings history
PE Ratio (TTM)0.1×htsuf pe ratio ttm · htsuf price to earningsPE Ratio deep dive
Revenue (TTM)$163.1Bhtsuf revenue ttm · htsuf annual revenueFull revenue history
Dividend Yield2.84%does htsuf pay dividends · htsuf dividend yieldDividend history
Shares Outstanding71.3Mhtsuf shares outstanding · htsuf floatShares outstanding history
Next EarningsJul 9, 2026Est.htsuf earnings date · htsuf next earningsEarnings history

Financial Snapshot

Full Financials
FY 2026Revenue$163.49B▲ +4.80% YoY
202420252026
hisamitsu pharmaceutical co., inc. revenue · htsuf revenue 2026
FY 2026Net Income$19.22B▼ 11.68% YoY
202420252026
hisamitsu pharmaceutical co., inc. net income · htsuf profit 2026
FY 2026EPS$269.27▼ 8.90% YoY
202420252026
htsuf eps · hisamitsu pharmaceutical co., inc. earnings per share 2026
TTM:Revenue: $163.09BNet Income: $19.17BEPS: $269.53View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-10.22%
5Y-52.46%

About Hisamitsu Pharmaceutical Co., Inc.

CEOKazuhide Nakatomi
IPO DateSep 23, 2010
Employees2,759
CountryJP

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, S…

what is hisamitsu pharmaceutical co., inc. · htsuf stock overview · hisamitsu pharmaceutical co., inc. company profile · who is hisamitsu pharmaceutical co., inc. ceo · htsuf OTC · hisamitsu pharmaceutical co., inc. headquarters · hisamitsu pharmaceutical co., inc. business segments

About Stock Overview & Key Data

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Sep 23, 2010. As of the latest trading session, HTSUF stock price is $29.00, with a market capitalization of $2.0B. The stock has returned -10.22% over the past 12 months and +0.00% year-to-date.

In fiscal year 2026, Hisamitsu Pharmaceutical Co., Inc. reported revenue of $163.5B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Hisamitsu Pharmaceutical Co., Inc. (HTSUF) stock price is $29.00. The stock is traded on OTC under the ticker symbol HTSUF. The 52-week range is $28.94 – $32.30.

HTSUF stock priceHTSUF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice